BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gan P, Xia Q, Hang G, Zhou Y, Qian X, Wang X, Ding L. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-κB signalling pathway in Parkinson's disease model. Clin Exp Pharmacol Physiol 2019;46:337-49. [PMID: 30485484 DOI: 10.1111/1440-1681.13052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao L, Wu J, Koc S, Lu G. Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements. Front Cell Dev Biol 2021;9:655819. [PMID: 34336822 DOI: 10.3389/fcell.2021.655819] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ge JW, Deng SJ, Xue ZW, Liu PY, Yu LJ, Li JN, Xia SN, Gu Y, Bao XY, Lan Z, Xu Y, Zhu XL. Imperatorin inhibits mitogen-activated protein kinase and nuclear factor kappa-B signaling pathways and alleviates neuroinflammation in ischemic stroke. CNS Neurosci Ther 2021. [PMID: 34674376 DOI: 10.1111/cns.13748] [Reference Citation Analysis]
3 Wu HC, Chang KH, Chiang MC, Chen CM. Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson's Disease. Brain Sci 2021;11:1515. [PMID: 34827514 DOI: 10.3390/brainsci11111515] [Reference Citation Analysis]
4 Mijanovic O, Petushkova AI, Brankovic A, Turk B, Solovieva AB, Nikitkina AI, Bolevich S, Timashev PS, Parodi A, Zamyatnin AA Jr. Cathepsin D-Managing the Delicate Balance. Pharmaceutics 2021;13:837. [PMID: 34198733 DOI: 10.3390/pharmaceutics13060837] [Reference Citation Analysis]
5 Oelschlaegel D, Weiss Sadan T, Salpeter S, Krug S, Blum G, Schmitz W, Schulze A, Michl P. Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages. Cancers (Basel) 2020;12:E2579. [PMID: 32927704 DOI: 10.3390/cancers12092579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jiang DQ, Ma YJ, Wang Y, Lu HX, Mao SH, Zhao SH. Microglia activation induces oxidative injury and decreases SIRT3 expression in dopaminergic neuronal cells. J Neural Transm (Vienna) 2019;126:559-68. [PMID: 31004314 DOI: 10.1007/s00702-019-02005-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gan P, Ding L, Hang G, Xia Q, Huang Z, Ye X, Qian X. Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease. Front Pharmacol 2020;11:776. [PMID: 32528295 DOI: 10.3389/fphar.2020.00776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]